Skip to main
REPL
REPL logo

Replimune Group Inc (REPL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy REPL Stock

About Replimune Group Inc (REPL)

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Market cap$753.91M
Today's volume680.24K
Revenue (TTM)
Avg. daily volume1.16M
EBITDA (TTM)-$259.92M
Open$9.66
Price / earnings ratio-3.05x
Today's range$9.65 - $9.94
Debt / equity18.32x
52 week range$6.44 - $17
5 year debt / equity11.99x
Beta (LTM)0.88x
Interest coverage-33.37x
Dividend & yield$0.00 (0.00%)
Current ratio7.95x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

REPL Stock Rating

What analysts recommend for REPL stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 54%
Buy 46%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for REPL stock is $753.91M

The current P/E ratio for REPL stock is -3.05

The 52-week high for REPL stock is $17. The current REPL stock price $undefined is 100.00% below its 52-week high

The 52-week low for REPL stock is $6.44. The current REPL stock price $undefined has increased 100.00% from its 52-week low

No, the REPL stock does not pay dividends to its shareholders

The target price for REPL stock is $30.46 based on the average of what a group of analyst think REPL stock could be worth at a future date. This is not a prediction by Public.com

How to buy REPL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in REPL stock

    Navigate to the Explore page. Then, type REPL into the search bar. When you see REPL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased REPL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Replimune Group Inc Stock Earnings

The value each REPL share was expected to gain vs. the value that each REPL share actually gained.

REPL (REPL) reported Q4 2025 earnings per share (EPS) of -$0.82, missing estimates of -$0.69 by 18.84%. In the same quarter last year, REPL's earnings per share (EPS) was -$0.82. REPL is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.

Buy REPL Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.